Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 02, 2018

SELL
$2.55 - $4.85 $31,171 - $59,286
-12,224 Closed
0 $0
Q3 2017

Oct 30, 2017

BUY
$4.5 - $5.65 $55,008 - $69,065
12,224
12,224 $64,000

About Adamis Pharmaceuticals Corp


  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Nj State Employees Deferred Compensation Plan Portfolio

Follow Nj State Employees Deferred Compensation Plan and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nj State Employees Deferred Compensation Plan, based on Form 13F filings with the SEC.

News

Stay updated on Nj State Employees Deferred Compensation Plan with notifications on news.